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oped that predicted the true distance and area with high statistical precision. (R2=0.99) 
Conclusion: Area measurements vary between different catheter systems indicating 
inconsistencies of their internal calibration scales, External calibration equations can cor- 
rect for these differences and allow the comparison of measurements inmulticenter intra- 
vascular ultrasound studies analyzing atherosclerotic disease progression. 
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1104-16 Calcification In Saphenous Vein Graft: Clinical 
Correlates and Intrevascular Ultrasound Findings 
Marco T. Castaona. Gary S. Mintz, Nell J. Weissman, Akiko Maehara, Jun-ichi Kotani, 
Javed M. Ahmed, Marfine Gilard, Daniel Canos, William O. Suddath, Lowell F. Satier, 
Ron Waksman, Kenneth M. Kent, Augusto D. Pichard, Washington Hospital Center, 
Washington, Dist of Columbia, Cardiovascular Research Foundation, New York, New 
York. 
Background: The ability of angiography to detect calcium is limited. Intravascular ultra- 
sound (IVUS) has been used to study calcification in native coronary arteries, but not in 
saphenous vein grafts (SVG's). Native artery calcium is more often located within lesions 
(vs reference segments) and in the plaque (vs the wall). Methods: We analyzed clinical 
and pre-intervention IVUS findings in 334 consecutive SVG's in 274 pts. IVUS measure- 
ments included arc and length of calcium at the lesion, 10mm proximal and distal refer- 
ence segments, as well as the whole SVG from distal anastomosis to aorto-ostial 
junction. Results: Calcium was found in 40% of SVGs. It was evenly distributed at lesion 
site (14%), proximal (13%) and distal (13%) reference segments, and elsewhere in the 
SVG (10%). Calcium was located primarily in the SVG wall, not in the plaque. In pts with 
calcium, the maximum arc at the proximal reference, lesion site, and distal reference 
averaged 175 ° , 151 ° and 177 ° , respectively, with maximum arc over the entire length of 
the SVG averaging 174 °. The table shows the clinical correlates of SVG calcification. 
SVG calcium occurred more commonly in older grafts, in insulin-treated diabetics (IDDM) 
and in smokers, Conclusion: Calcium occurs commonly in SVG's; however, patterns 
and clinical correlates are distinctly different from native arteries. This suggests that SVG 
calcium is a result of SVG wall degeneration is not part of SVG lesion formation and mat- 
uration. 
No Calcium Calcium p 
SVG age, years 7.5 10.5 <0.0001 
IDDM, % 40 60 0.02 
Tobacco use, % 44 55 0.060 
Hypertension, % 60 40 0.9 
Dilipidemia, % 60 40 0.6 
Renal Insufficiency, % 55 45 0.5 
1104-17 Negative Remodeling Is a Predominant Mechanism for 
Lumen Compromise in Intermal Mammary Artery 
Stenosie Formation: An Intrevaeculer Ultrasound Study 
Javed M. Ahmed. Gary S. Mintz, Marco T. Castagna, Marco Zamirino, Augusto D. 
Pichard, Lowell F. Salter, Kenneth M. Kent, Neil J. Weissman. 
To better understand the mechanism of stenosis formation in intemal mammary arlery 
(IMA), we used pre-intervention i travascular ultrasound (IVUS) imaging to study 
41 patients (41 IMA lesions: 15 ostial, 23 anastomosis, 3distal shaft) undergoing percuta- 
neous intervention (PCI). IVUS measurements included reference and lesion site vessel 
area (EEM CSA), lumen area, plaque (vessel-lumen area) and plaque burden (plaque/ 
vessel area), and arc of calcium in degrees. The lesion EEM CSA was compared to the 
reference; positive remodelling was defined as lesion > reference EEM CSA (remodelling 
index _> 1.0) and negative remodelling was defined as lesion < reference EEM CSA 
(remodelling index < 1.0). 
Conclusion. IMA stenosis is distinctly different from coronary artery disease. In IMA 
stenosis, pre-intervention IVUS demonstrated that (1) reference plaque burden is mod- 
est, (2) negative remodelling contributes importantly to lumen compromise at both ostial 
and anastomotic sites, and (3) there is no significant calcium at either site. 
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Ost ia l  Anastomosis P 
Refrenco EEM CSA, mm 2 10.8+1.18 10.6tO.85 0.58 
Reference Lumen CSA, mm 2 7.9tO.92 7.9-+1.27 0.67 
Reference P&M CSA, mm 2 2.9-J:0.66 2.6-+o.76 0.31 
Reference plaque burden 25_+6 25+6 0.51 
Lesion EEM CSA, mm 2 7.05:1.17 6.7±0.85 0.38 
Lesion lumen CSA, mm 2 2.4-+0.82 2.7±0.58 0.16 
Lesion P&M CSA, mm 2 4.6_+0.62 4.0i~.61 0.004 
Lesion plaque burden 66±7 59-+6 0.005 
Lesion Ca (°) 16.8±26.9 2.0t-9.5 0.04 
Remodeling index 0.63±0.07 0.64±0.06 0.58 
1104-18 Different Mechanism of Lumen Enlargement in Lesions 
With Stent Underexpansion After Balloon Angiopleety 
for In-Stent Restenosis Compared to Those With 
Optimal Stent Expansion: An Intrsvasculsr Ultrasound 
Study 
Farzana Adf. Yoshio Kobayashi, Makoto Hirose, Octavia Balan, Arlene Reyes, Ioannis 
lakovou, Milena Adamian, Roxana Mehran, George Dangas, Alexandra J. Lansky, Issam 
Mousse, Gregg W. Stone, Martin B. Leon, Jeffrey W. Moses, Gary S. Mintz, 
Cardiovascular Research Foundation, New York, New York. 
Background: The mechanism of lumen enlargement after angioplasty (PCI) for in-stent 
restenosis (ISR) is a combination of further stant expansion and redistribution of intimal 
hyperplasia. However, the effect of stent underexpansion on lumen enlargement after 
PCI for ISR is not fully evaluated. 
Methods: Intravascular ultrasound (IVUS) was performed in 166 lesions with ISR. Those 
were divided in two groups: (1) stant underexpansion defined as stent area <7.0 mm 2 
and <80% of reference lumen area (n=55) and (2) optimal expansion (n=111), Calcified 
plaque behind slant struts was defined as calcium arc > 180 °. 
Conclusions: Stent underexpansion is observed in 33% of ISR lesions and is frequently 
associated with calcified plaque morphology. Further stant expansion is the main mecha- 
nism of lumen enlargement in these lesions. However, even using higher balloon pres- 
sures, post-PTCA stent and lumen CSA are smaller than lesions in which the stent was 
optimally expanded initially. 
Results 
Optimal Underexpansion p Value 
Calcium behind stent (%) 4 33 <0.01 
Reference CSA (mm 2) 6.8-+2.4 5.7±1.8 0.01 
Pre-lumen CSA (mm 2) 1.9±1.0 2.3±1.0 0.07 
Pre-stent CSA (mm 2) 6.7±1.9 3.9±0.9 <0.01 
Pre-intima CSA (mm 2) 4.9~1.7 1.7±1.3 <0.01 
B/V ratio 1.17:L-0.13 1.15+0.15 NS 
Max. inflation pressure (atm) 13.8+4.0 15.8+4.2 <0.01 
Post lumen CSA (mm 2) 6.0:t:1.6 4.8+1.4 <0.01 
Post stent CSA (mm 2) 8.2+9.2 5.6+1.8 <0.01 
Post intima CSA (mm 2) 2.2+1.4 0.8~0.8 <0.01 
A lumen CSA (mm 2) 4.2±1.4 2.7+1.8 <0.01 
,', stent CSA (mm 2) 1.7±1.0 1.7±1.6 NS 
~, intima CSA (mm 2) 2.5+1.2 1.2~0.9 <0.01 
,1 stent CSA / ,1 lumen CSA 39+~?.0 53_+32 0.04 
1104-19 Severity of the Worst Lesion Correlates With Total 
Plaque Burden in a Coronary Artery: In Vivo Analysis in 
Patients With Mild, Moderate, and Severe 
Atheroeclerosis 
Samir R. Kaoadia. Fernando A. Cura, Paul Schoenhagen, Jennifer Popovich, Robert E. 
Hobbs, Staven E. Nissen, E. M. Tuzcu, University of Washington, Seattle, Washington, 
Cleveland Clinic Foundation, Cleveland, Ohio. 
Background: Active coronary atherosclerosis has been associated with signs of sys- 
temic inflammation. If atherosclerosis were a diffuse, generalized process, plaque area at 
the site with worst tesion would correlate with the total plaque volume in that vessel To 
test this hypothesis, we compared the worst plaque area to total plaque burden in 
patients with mild, moderate and severe atherosclerosis. Methods: Mild atherosclerosis 
group consisted of 171 donor hearts, studied within 60 days of transplantation. Moderate 
atherosclerosis group included 279 patients with <50% stenosis and severe atherescle- 
rosis group consisted of 79 patients undergoing percutaneous intervention for severe 
(>70%) stenosis. Automated pullback sequences were obtained in all patients. Plaque 
volumes were calculated by measuring all sites separated by 1 ram. Total plaque volume 
was correlated with the worst plaque area. Results: We ana;yzed 6207 sites from 171 
patients with mild, 12031 sites from 279 patients with moderate and 2001 sites from 79 
patients with severe atheroscleresis. Irrespective of the sevedty of atherosclerosis, there 
JACC March 6, 2002 ABSTRACTS - ACCIS2002 (Angiography & Interventional Cardiology) 
was a strong correlation between total plaque volume in a vessel and plaque area at the 
site with worst lesion. (Figure) 
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Conclusion: Plaque area of the most severe lesion in a coronary artery reflects totat 
plaque burden in patients with mild, moderate or severe athercsclerosis. This finding 
adds to the evidence that coronary atherosclerosis a diffuse and generalized process. 
1104-20 Di f ferent  Mechanism of Lumen Enlargement During 
Balloon Angioplasty Between Focal and Diffuse In-Stent 
Restenosis 
Makoto Hirosa. Yoshio Kobayashi, Farzana Arif, Octavia Balan, Arlene Reyes, Ioannis 
lakovou, Costantino Costantini, Issam Mousse, George Dangas, Roxana Mehran, 
Alexandra J. Lansky, Gregg W. Stone, Gary S. Mintz, Martin B. Leon, Jeffrey W. Moses, 
Cardiovascular Research Foundation, New York, New York. 
Background: The mechanism of lumen enlargement after angioplasty for in-stent rest- 
enosis (ISR) is a combination of further stent expansion and redistribution of intimal 
hyperplasia. However, contribution of further stent expansion and redistribution of intimal 
hyperplasia to lumen enlargement may be different between focal and diffuse in-stent 
restesnosis. 
Methods: Intravascular ultrasound (IVUS) was performed in 47 lesions with ISR before 
and after balloon angioplasty. Those were divided in two groups according to lesion 
length measured by QCA: 1) focal (<20mm, n=21) and 2) diffuse (>~20mm, n=26). IVUS 
images of the stented segment were measured every 0.5 mm. 
Conclusions: Plaque re-distribution within stent is the main mechanism of lumen 
enlargement during balloon angioplasty in focal ISR, In contrast, furthur stent expansion 
is the main mechanism for diffuse ISR. 
Results 
Focal (n=21) Diffuse (n=26) p Value 
Mean reference lumen CSA (mm 2) 8.0-i-_4.6 6.5:~?..1 0.30 
Pre-intervention 
Minimal lumen CSA (mm 2) 1.9±0.8 1.6_+0.6 0.21 
Stent CSA (ram 2) 7.1±3.1 5.7_+1.6 0.06 
Neointima CSA (mm 2) 5.2+2.7 4.0±1.4 0~08 
Mean lumen CSA (mm 2) 4.0±1.8 3.0±1.2 0.04 
Mean stent CSA (mm 2) 7.3_+3.1 6.3_+1.4 0.17 
Mean neointima CSA (mm 2) 3.3_+1.7 3.2±1.1 0.95 
Post-intervention 
Minimal lumen CSA (mm 2) 5.2±2.0 5.1_+2.0 0.84 
Stent CSA (ram 2) 8.1 _+3.1 7.5±2.7 0.43 
Neointima CSA (mm 2) 2.9~1.9 2.3+1.2 0.27 
Mean lumen CSA (mm 2) 5.6_+1.9 5.9±2.0 0.67 
Mean stent CSA (mm 2) 8.1_+2.8 8.2+~.2 0.98 
Mean neointima CSA(mm 2) 2.5±1.2 2.3+0.8 0.45 
AStent CSNALumen CSA 0.27 0.53 0.03 
ANeointima CSA/ALumen CSA 0.73 0.47 0.03 
/',Mean lumen CSA (mm 2) 1.6±1.1 2.8±1.9 0.007 
AMean stent CSA (mm 2) 0.9~1.1 1.9±1.6 0.01 
AMean neointima CSA (mm 2) -0.7+0.7 -1.0~0.9 0.38 
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823-1 S i ro l imus-E lut ing  Stents  Abo l i sh  Neo int imal  
Hyperp las la  In Patients With In-Stent Restenoels: Late 
Angiographic and Intravascular Ultrasound Results 
Patrick W. Serruvs, Alexandre Abizaid, David Fotey, Andrea Abizaid, Pim de Feyter, 
Jeffrey Popma, Muzaffer Degertekin, Rodolfo Staico, thraim Pinto, Egon Wuelfert, 
Amanda Souse, J. Eduardo Sousa, Institute Dante Pazzanese of Cardiology, Sac Paulo, 
Brazil, Thoraxcenter - University Hospital Dijkzigt, Rotterdam, The Netherlands. 
Background: We previously reported the long-term efficacy of sirolimus-coated BX 
Velocity stent (Cypher TM) to treat de novo coronary lesions. The objective of this study 
was to assess the safety and efficacy of this new drog-eluting stent for the treatment of 
in-stent restenosis (ISR). Methods: Forty patients with ISR in native coronary arteries 
were successfully treated with >1 Cypher TM stent (1.4 stents/lesion) in this prospective 
registry. Angiography and volumetric IVUS quantification was performed in all pts at 
baseline and will be repeated at 4 months to determine the amount of neo-intimal prolif- 
eration, Reeults: Thusfar. 22 pts have completed anglo and IVUS follow-up. Mean age 
was 56+13 years, 82% were male and 15% were diabetics. Lesion length was 
17.2+9.7mm. At present (mean follow-ups102+64 days) the incidence of major cardiac 
events is 2.5% (1 sudden death at 4 months, no MIs, and no repeat revascularization). 
Angiographic and IVUS data are in the table. 
Post procedure Follow-up 
Angiogrephy 
Referrence diameter (mm) 2.85_+0.32 2.84_+0.41 
Binary restenosis (%) N/A 0 
Minimum lumen diameter (ram) 2.71_+0.26 2.63±0.31 
Late loss (mm) N/A 0.09 
IVUS 
Stent volume (mm3) 140.2±49.7 140.2+49.7 
Lumen volume (mm3) 140.2±49.7 134.5±48.9 
Intimal hyperplasia volume (mm3) N/A 6.3±5.6 
% of obstruction N/A 5% 
Conclusion: In this preliminary registry, the treatment of in-stent restenosis using the 
Cypher TM stent showed 1) no angiographic restenosis; 2) infrequent cardiac events 
(2.5%); and 3) minimal (5%) IVUS in-stent obstruction. Follow-up of the complete patient 
cohort will be presented 
2:15 p.m. 
823-2 Is There an Edge Effect With the Sirolimua-Eluting 
Stent? 
,Jo~e Eduardo E. Sousa. K. Tanabe, M. Degertekin, J. Fajadet, M. Perin, E. Ban Hayashi, 
A. Colombo, M. C. Morice, P. W. Serruys, C. Demeyere, Thoraxcenter, Rotterdam, The 
Netherlands. 
Background: Sirolimus-eluting stent (SES) is emerging as a potential solution for the 
prevention of restenosis. However, we have to establish that SES does not produce edge 
restenosis as seen in radioactive stents. The objective of this study is to compare the 
edges of Sirolimus-eluting Bx VELOCITY tm stent (Cordis) with those of uncoated Bx 
VELOCITY tm stent (US) in the RAVEL study, a double-blind, randomized and controlled 
trial Methods: We assessed the post-procedural and 6-month follow-up angiograms of 
238 patients enrolled in the RAVEL study. Quantitative coronary angiography (QCA) was 
performed with the CAAS II system. Three segments were selected for QCA : the stented 
segment and two edge segments that were axially 5 mm proximal and distal to the stent 
margins. Results: 212 patients had angiographic follow-up. (105 patients in SES group, 
107 patients in US group). 
MLDpoet(mm) MLD6-month(mm) P-value LeteLou  
oroxlmal edce SES 2.47_+0.53 2.41±0.58 NS 0.05±0.40 
US 2.46_+0.54 2.18_+0.63 .001 0.29~0.48 
In-stent SES 2.43±0.41 2.42+0.49 NS -0.01±0.33 
US 2.41±0.40 1.64+0.58 .000 0.80~).53 
distal edoe SES 2.13+0.47 2.20~0.51 NS -0.10~O.30 
US 2.21±0.51 2.11_+0.50 NS 0.11¢0.43 
In each segment of SES, postprocedural MLD remained basically unchanged at follow- 
up. In addition, the late loss of SES group is significantly lower than that of the US 
group(P=0.0001). Conclusion: Elution of Sirolimus not only fully inhibits neointimal 
hyperplasia within the stent but also prevents the edge effect seen mainly proximally with 
the uncoated stent. 
